Leveraging C-END E3 Ligases for PROTAC Development - 4th Ligase Targeting Drug Development Summit

Skip to content

THIS EVENT HAS BEEN CANCELLED

Home
About
Partner
- Why Partner?
- Partners
Register Interest
- Register Interest
- Contact Us

Leveraging C-END E3 Ligases for PROTAC Development

Time: 9:30 am
day: Day One

Speakers:

Daniel Scott

JOIN THE LINKEDIN COMMUNITY

VENUE

The Colonnade
120 Huntington Ave,
Boston, MA 02116,
United States

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok